Poster session B

• B.1.1: Bacterial susceptibility of Escherichia coli in urinary tract infections in the hospital setting.
  Dr. Axel Jeurissen
  
  
• B.1.2: Do Norwegian hospitals have guidelines for the use of antibiotics prior to cholecystectomies?
  Dr. Oliver Kacelnik
  
  
• B.1.3: The changing antimicrobial susceptibility of bloodstream infections in the first month of life; informing antibiotic policies for early and late onset sepsis.
  Ms Ruth Blackburn
  
  
• B.1.4: Epidemiology and antimicrobial resistance profiling of Pseudomonas aeruginosa in a Greek University Hospital.
  Dr. Eleni Jelastopulu
  
  
• B.1.5: Antimicrobial-Resistance-Monitoring in Lower Saxony (Germany): the sentinel system ARMIN.
  Dr. Martina Scharlach
  
  
• B.1.6: Methicillin-resistant Staphylococcus aureus (MRSA) in a Canadian sub-Arctic community: Descriptive epidemiology from an outbreak encourages renewal of community control measures.
  Ms. Katie Rutledge-Taylor
  
  
• B.1.7: Cases of community-acquired meticillin-resistant Staphylococcus aureus in an asylum seekers centre in Northern Germany, November 2010.
  Ms. Sandra Dudareva
  
  
• B.1.8: Male urinary tract infections in Dutch general practices.
  Mr. Casper den Heijer
  
  

• B.1.9: Investigation of high-level resistance to multiple-aminoglycosides in clinical isolates of Enterobacteriaceae in Poland.
  Ms. Katarzyna Zacharczuk

• B.1.10: Fluoroquinolones use in French hospitals in 2008 and 2009. Data from the nationwide network “ATB-RAISIN”.
  Dr. Catherine Dumartin
  
  

• B.2.1: Estimating time-variability in fatality and spontaneous recovery rates for untreated active pulmonary TB.
  Dr. Lorenzo Sabatelli
  
  
• B.2.2: Dynamic simulation of Meningococcal Disease in Portugal after introduction of MenC vaccine.
  Dr. Maria João Simoes
  
  
• B.2.3: The use of mathematical models to explore the existence of an outbreak of suspected post-cataract surgery endophthalmitis in a district general hospital in London in 2010.
  Dr. Arnaud Le Menach
  
  

• B.2.4: Can changes in patterns of migration result in new HIV outbreaks among heterosexuals in Europe?
  Dr. Maria Xiridou
  

  (Withdrawn)

• B.2.5: Person-to-person inter-individual contact patterns and the spread of epidemics. Descriptive analysis.
  Mr. Rubén Solano
  
  
• B.2.6: Using auto-regressive integrated moving average (ARIMA) time series analysis to model frequent causes of bloodstream infection.
  Dr. David Jenkins
  
  

• B.2.7: Transmission and control in an institutional outbreak of pandemic influenza A (H1N1) 2009.
  Dr. Nika Raphaely
  

  (Withdrawn)

• B.2.8: Controlling varicella and zoster: the challenge of rational opposition to the varicella vaccine.
  Prof. Piero Manfredi
  
  

• B.3.1: The year culminated in a disastrous Christmas meal: Investigating an increase in listeriosis, Finland 2010.
  Dr. Ruska Rimhanen-Finne
  
  
• B.3.2: Disease burden of (foodborne) norovirus illness in the Netherlands in 2009.
  Dr. Linda Verhoef
  
  
• B.3.3: Acute Flaccid Paralysis: epidemiologic surveillance in Emilia Romagna Region (Italy) 1996 – 2010.
  Dr. Matteo Riccò
  
  
• B.3.4: Large outbreak of Shigellosis associated with contaminated water supply in rural villages, Chiangmai province, Thailand, October 2010.
  Dr. Jamorn Makaroon
  
  
• B.3.4: What caused the Campylobacter outbreak- people, parfait or poultry?
  Dr Giri Shankar
  
  
• B.3.5: Persistent gastrointestinal symptoms among immunocompetent individuals following a foodborne microsporidiosis outbreak in Sweden, 2009
  Dr Valerie Decraene
  
  
• B.3.6: An investigation of the largest typhoid outbreak in Thailand, October 2009 – April 2010.
  Dr. Narong Henprasertthae
  
  
• B.3.7: Campylobacter outbreak in a school in Barcelona.
  Mr. Sarah Lafuente van der Sluis
  
  
• B.3.8: Waterborne outbreak of Hepatitis A in adults in a Thai-Cambodian border district, Thailand, October 2010- February 2011.
  Dr. Tanapol Wangteeraprasert
  
  
• B.3.9: Campylobacteriosis Outbreaks and Raw Milk Consumption, Hesse, Germany, 2005-2010.
  Ms Sarah McFarland
  
  
• B.3.10: Hospital based case-control study on risk factors for systemic Salmonella enterica spp. infections in Ghana
  Dr. Norbert Schwarz
  
  
• B.3.11: A survey on criteria used by Italian general practitioners in prescribing laboratory investigation for acute gastrointestinal illness.
  Dr. Francesca Baldinelli
  
  

• B.5.1: Communicable diseases surveillance during mass gathering: the 6th Francophone games, Lebanon, 2009.
  Ms Nadine Haddad
  
  
• B.5.2: Implementation of a surveillance system in place for the 2010 Ryder Cup golf competition in Wales.              
  Ms Maria Keramarou
  
  
• B.5.3: Survey system for an academic week in Portalegre.
  Mrs. Andreia Costa
  
  
• B.5.4: Health Protection Event Based Surveillance for London 2012 Olympic Games.
  Mr. Ettore Severi
  
  
• B.5.5: Early warning system in migrant detention centres, Evros region, Greece 2011.
  Ms. Anoek Backx
  
  
• B.5.6: Gastrointestinal disease outbreaks in cycling events: Are control measures being effective?
  Dr. Ricardo Mexia
  
  

• B.6.1: Evaluation of Shigellosis Surveillance System in Armenia, 2010.
  Dr. Lilit Avetisyan
  
  
• B.6.2: Local Public Health Authorities’ Perception of the German Infectious Diseases Surveillance System.
  Dr. Mona Askar
  
  
• B.6.3: Poor sensitivity of the Slovenian Surveillance System for Sexually Transmitted Infection with Chlamydia trachomatis.
  Mrs. Tanja Kustec
  
  
• B.6.4: Burden of communicable disease in Germany – preliminary results from the Burden of Communicable Diseases in Europe (BCoDE) pilot study.
  Mr. Dietrich Plass
  
  
• B.6.5: How the choice of laboratory methods affects the surveillance of enteropathic Escherichia coli in Germany.
  Ms. Hélène Englund
  
  
• B.6.6: Timeliness of hepatitis B notification: a comparison between laboratories and the effect of the new law on Public Health in the Netherlands.
  Mrs. Corien Swaan
  
  
• B.6.7: The performance of mandatory and sentinel surveillance systems for communicable diseases: lessons to learn from the Italian experience.
  Dr. Chiara de Waure
  
  
• B.6.8: 10 years of mandatory Creutzfeldt-Jakob Disease surveillance in Germany, 2001-2010.
  Dr. Maria Wadl
  
  
• B.6.9: Estimation of the completeness of the surveillance for Salmonella Typhi and Paratyphi – Denmark, 2000-2010.
  Mrs. Charlotte Kjelsø
  
  
• B.6.10: Human Tularemia Surveillance System Evaluation in Georgia, 2006-2010.
  Ms. Sophio Datukishvili
  
  
• B.6.11: Evaluation of the Surveillance System for Legionnaire’s disease in Portugal 2004-2010.
  Dr. Dafina Dobreva
  
  
• B.6.12: Evaluation of Surveillance System for Hepatitis B in Pregnant Women in Baku, Azerbaijan May 2009 – July 2010.
  Dr. Khanim Salahova
  
  

• B.7.1: Simultaneous TB and HIV diagnosis in CoRIS patients, in Spain.
  Dr. Vinciane Sizaire
  
  
• B.7.2: Identical toxigenic Corynebacterium ulcerans strain in a patient with diphtheria-like illness and her asymptomatic cat.
  Dr. Andreas Sing
  
  

• B.7.3: High Prevalence Of Subclinical Tuberculosis In HIV-1 Infected Persons Without Advanced Immunodeficiency in South Africa: Implications For TB Screening.
  Dr. Tolu Oni
  

  (Withdrawn)

• B.7.4: Tendency of tobacco smoking among tuberculosis patients in a big city.
  Ms. Àngels Orcau
  
  
• B.7.5: Multicentre study for assessment of the laboratory ability to detect enterovirus 68, an emerging respiratory pathogen.
  Dr. Giovanna Jaramillo-Gutierrez
  
  
• B.7.6: Tuberculosis Treatment Outcome Monitoring: how underlying definitions determine success rates – a review from a German perspective.
  Ms. Sofie Gillesberg Lassen
  
  
• B.7.7: The United Kingdom Tuberculosis Port of Entry Migrant Screening Programme: study on yields, screening tool validity and groups at increased risk for Tuberculosis among new entrants in 2009 and 2010.
  Mr. Ettore Severi
  
  
• B.7.8: Healthcare resources utilization in relation to patients suffering from prolonged cough, suspected of pertussis in Poland, 2009-2010
  Ms Ewa Karasek
  
  
• B.7.9: Post mortem diagnosis of tuberculosis in the European Union and European Economic Area, 2009.
  Dr. Vahur Hollo
  
  
• B.7.10: Mycobacterium tuberculosis isolates showed high degree of genetic diversity and association with drug resistance in Nepal.
  Mr. Bijaya Malla
  
  

• B.8.1: A mixed outbreak of rubeola-rubella in District Kangra of Northern India.
  Dr. Surender Gupta
  
  
• B.8.2: Epidemiological investigation of mixed outbreaks of measles/varicella in hilly villages of district Kangra, Himachal Pradesh, India, 2007.
  Dr. Surender Gupta
  
  
• B.8.3: Is diphtheria re-emerging? The French point of view.
  Mr. Emmanuel Belchior
  
  
• B.8.4: Measles in London and the South East of England – what can we learn from the returning epidemic?
  Dr. Dominik Zenner
  
  
• B.8.5: Mumps in Spain 2008-2010.
  Mrs. Elga Mayo-Montero
  
  
• B.8.6: 2011: Measles reaches Barcelona.
  Mrs. Sarah Lafuente van der Sluis
  
  
• B.8.7: Smallpox in the Medici family, Florence, Italy, 1519-1737 – a historical cohort study.
  Mr. Saverio Caini
  
  
• B.8.8: Estimation of burden of rotavirus infections in children <5 years old in Poland.
  Ms Justyna Rogalska
  
  
• B.8.9: Epidemiology and surveillance of invasive meningococcal disease (IMD) in Ireland, 2010.
  Dr. Suzanne Cotter
  
  
• B.8.10: The Epidemiology of Invasive Meningococcal Disease in Europe, 2008-2009.
  Dr. Ida Czumbel
  
  
• B.8.11: Emergence of invasive meningococcal disease in Europe, 2007-2009.
  Dr. Ida Czumbel
  
  

• B.9.1: Outbreak of Avian Influenza H9 in a poultry farm, East of England, 2010.
  Mr. Chris Williams
  
  
• B.9.2: Rift Valley fever: A need for a One Health One World approach. Case study from Sudan.
  Mr. Osama Ahmed Hassan
  
  
• B.9.3: Q fever vaccination campaign for medical high risk patients in the Netherlands.
  Ms. Leslie Isken
  
  
• B.9.4: Just Counting Sheep? Ecological Associations of Q-Fever Incidence and Ruminant Density in Germany.
  Dr. Christina Frank
  
  
• B.9.5: Avian influenza A(H5N1) in humans: new insights from constructing a line list of WHO confirmed cases.
  Dr. Lena Fiebig
  
  
• B.9.6: Risk factors for Q fever infection in a large outbreak in a rural setting in Southwest Germany, 2010.
  Mr. Alper Kilic
  
  
• B.9.7: Study of main causes of death following hantavirus infection in Sweden.
  Dr. Anne-Marie Connolly-Andersen
  
  
• B.9.8: A cluster of Hepatitis E infections in the south of France, linked to raw consumption of briefly smoked fresh pork liver sausages and seafood, February-March 2011.
  Ms. Anoek Backx
  
  
• B.9.9: Seroprevalence of antibodies against Francisella tularensis (Tularaemia) in nine municipalities in South West Germany, 2008.
  Mrs. Christiane Wagner-Wiening
  
  
• B.9.10: Analysis of factors associated with Salmonella pen positivity in holdings with breeding pigs, EU-wide baseline survey, 2008.
  Dr. Giusi Amore